These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3819937)

  • 1. Growth hormone secretory dynamics in children with precocious puberty.
    Ross JL; Pescovitz OH; Barnes K; Loriaux DL; Cutler GB
    J Pediatr; 1987 Mar; 110(3):369-72. PubMed ID: 3819937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.
    Attie KM; Ramirez NR; Conte FA; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1990 Oct; 71(4):975-83. PubMed ID: 2401720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
    Juul A; Fisker S; Scheike T; Hertel T; Müller J; Orskov H; Skakkebaek NE
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatomedin-C in accelerated growth of children with precocious puberty.
    Pescovitz OH; Rosenfeld RG; Hintz RL; Barnes K; Hench K; Comite F; Loriaux DL; Cutler GB
    J Pediatr; 1985 Jul; 107(1):20-5. PubMed ID: 3891947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
    Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF
    J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA; Manasco PK; Barnes KM; Jones J; Rose SR; Hill SC; Cutler GB
    J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
    Rappaport R; Prevot C; Brauner R
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone secretory patterns in children with short stature.
    Costin G; Kaufman FR
    J Pediatr; 1987 Mar; 110(3):362-8. PubMed ID: 3819936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty.
    Cara JF; Burstein S; Cuttler L; Moll GW; Rosenfield RL
    J Pediatr; 1989 Jul; 115(1):64-8. PubMed ID: 2738797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone secretory dynamics in subjects with normal stature.
    Costin G; Kaufman FR; Brasel JA
    J Pediatr; 1989 Oct; 115(4):537-44. PubMed ID: 2795343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty.
    DiMartino-Nardi J; Wu R; Fishman K; Saenger P
    J Clin Endocrinol Metab; 1991 Oct; 73(4):902-6. PubMed ID: 1909708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A; Rivarola MA
    Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
    Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel testis-stimulating factor in familial male precocious puberty.
    Manasco PK; Girton ME; Diggs RL; Doppman JL; Feuillan PP; Barnes KM; Cutler GB; Loriaux DL; Albertson BD
    N Engl J Med; 1991 Jan; 324(4):227-31. PubMed ID: 1898671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone.
    Johansen JS; Giwercman A; Hartwell D; Nielsen CT; Price PA; Christiansen C; Skakkebaek NE
    J Clin Endocrinol Metab; 1988 Aug; 67(2):273-8. PubMed ID: 3260598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein.
    DiMartino-Nardi J; Wu R; Varner R; Wong WL; Saenger P
    J Clin Endocrinol Metab; 1994 Mar; 78(3):664-8. PubMed ID: 8126139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.